1 | minimum | 5,210 |
2 | finite | 547 |
3 | myriad | 158 |
4 | half-maximal | 67 |
5 | mid-range | 26 |
6 | midrange | 20 |
7 | polarizable | 18 |
8 | circe | 14 |
9 | p+ | 14 |
10 | pd-specific | 14 |
11 | 15-mm | 11 |
12 | two-alternative | 11 |
13 | dehydration-responsive | 9 |
14 | 23-h | 7 |
15 | 4-class | 7 |
16 | rectoanal | 7 |
17 | surfeit | 7 |
18 | terrace | 7 |
19 | double-labeled | 6 |
20 | hewlett-packard | 6 |
21 | j-p2/3 | 6 |
22 | mc-lr/cyn | 6 |
23 | nres | 5 |
24 | university-wide | 5 |
25 | 'lowest | 4 |
26 | 120-kda | 4 |
27 | 200-cm | 4 |
28 | double-peak | 4 |
29 | higher-energy | 4 |
30 | low-alcohol | 4 |
31 | melanin-like | 4 |
32 | multifibre | 4 |
33 | nonefficacy | 4 |
34 | orf513 | 4 |
35 | proximal-distal | 4 |
36 | smaller-than-expected | 4 |
37 | vademecum | 4 |
38 | 3-to | 3 |
39 | 4-to | 3 |
40 | 6-carbon | 3 |
41 | berlin-frankfurt-munster | 3 |
42 | igg-associated | 3 |
43 | mr-visualized | 3 |
44 | population-derived | 3 |
45 | preidentified | 3 |
46 | roc-derived | 3 |
47 | six-member | 3 |
48 | w-box | 3 |
49 | 'uniform | 2 |
50 | 10-year-survival | 2 |
51 | 2,2-diphenyl-1-picryl-hydrozyl | 2 |
52 | 20-hr | 2 |
53 | 4-hydroxypiperidine | 2 |
54 | 6-to | 2 |
55 | ache/buche | 2 |
56 | bregma | 2 |
57 | concentration-dependant | 2 |
58 | eco-environmental | 2 |
59 | fenofibrate-associated | 2 |
60 | four-alternative | 2 |
61 | galβ1-3galnac | 2 |
62 | improved-free | 2 |
63 | low-pitched | 2 |
64 | menc-specific | 2 |
65 | mitochondrial-like | 2 |
66 | onetime | 2 |
67 | q-deformed | 2 |
68 | subminimal | 2 |
69 | trial-registration | 2 |
70 | venusil | 2 |
71 | wash-off | 2 |
72 | α-amylase/α-glucosidase | 2 |
73 | 'presumed | 1 |
74 | 1/8xminimum | 1 |
75 | 142/193 | 1 |
76 | 20-msv | 1 |
77 | 5.345 | 1 |
78 | 50-cm | 1 |
79 | 5500-ml | 1 |
80 | 6-contact | 1 |
81 | 6to | 1 |
82 | aepg | 1 |
83 | algal-growth | 1 |
84 | analyte-dependent | 1 |
85 | anti-secretory/acid | 1 |
86 | barrier-protected | 1 |
87 | bodyweight-adjusted | 1 |
88 | burkard | 1 |
89 | carbohydrate-predominant | 1 |
90 | cd40-promoted | 1 |
91 | chorismate-derived | 1 |
92 | concentration/minimum | 1 |
93 | cone-guided | 1 |
94 | curve/minimum | 1 |
95 | dapk-related | 1 |
96 | derivative-are | 1 |
97 | desk-top | 1 |
98 | dir-deformed | 1 |
99 | dosing/minimum | 1 |
100 | effects-an | 1 |
101 | four-ring | 1 |
102 | half‑maximal | 1 |
103 | heat-fraction-limited | 1 |
104 | heterosegmental | 1 |
105 | hyper-corrective | 1 |
106 | igg-dependent | 1 |
107 | introdução | 1 |
108 | isodense | 1 |
109 | itim-bearing | 1 |
110 | lower-than | 1 |
111 | lpp1was | 1 |
112 | maintenance-focused | 1 |
113 | metal-enhanced | 1 |
114 | microfinite | 1 |
115 | mid-winter | 1 |
116 | miminum | 1 |
117 | minimun | 1 |
118 | naloxone-insensitive | 1 |
119 | naloxone-mediated | 1 |
120 | night-and | 1 |
121 | non-aroclor | 1 |
122 | non-mydriatric | 1 |
123 | non-soluble | 1 |
124 | nrs-based | 1 |
125 | oligodynamic | 1 |
126 | p-leg | 1 |
127 | parallel-elastic | 1 |
128 | pedi-cap® | 1 |
129 | ppar-response | 1 |
130 | pre-emptive/post-surgery | 1 |
131 | prospectively-defined | 1 |
132 | protein-engineered | 1 |
133 | pré-incubação | 1 |
134 | rac-arpin-arp2/3 | 1 |
135 | rac-wave-arp2/3 | 1 |
136 | randomized-by-site | 1 |
137 | sars-cov-induced | 1 |
138 | semi-indispensable | 1 |
139 | sp1-like | 1 |
140 | spread-out | 1 |
141 | sub-minimum | 1 |
142 | subgroup-the | 1 |
143 | subminimum | 1 |
144 | torso-vest | 1 |
145 | tri-modality | 1 |
146 | tumour-necrosis-factor-related | 1 |
147 | vl-absorbing | 1 |
148 | window-mounted | 1 |
149 | ~0.113 | 1 |
1 | 'lowest | 4 |
2 | 'presumed | 1 |
3 | 'uniform | 2 |
4 | 1/8xminimum | 1 |
5 | 10-year-survival | 2 |
6 | 120-kda | 4 |
7 | 142/193 | 1 |
8 | 15-mm | 11 |
9 | 2,2-diphenyl-1-picryl-hydrozyl | 2 |
10 | 20-hr | 2 |
11 | 20-msv | 1 |
12 | 200-cm | 4 |
13 | 23-h | 7 |
14 | 3-to | 3 |
15 | 4-class | 7 |
16 | 4-hydroxypiperidine | 2 |
17 | 4-to | 3 |
18 | 5.345 | 1 |
19 | 50-cm | 1 |
20 | 5500-ml | 1 |
21 | 6-carbon | 3 |
22 | 6-contact | 1 |
23 | 6-to | 2 |
24 | 6to | 1 |
25 | ache/buche | 2 |
26 | aepg | 1 |
27 | algal-growth | 1 |
28 | analyte-dependent | 1 |
29 | anti-secretory/acid | 1 |
30 | barrier-protected | 1 |
31 | berlin-frankfurt-munster | 3 |
32 | bodyweight-adjusted | 1 |
33 | bregma | 2 |
34 | burkard | 1 |
35 | carbohydrate-predominant | 1 |
36 | cd40-promoted | 1 |
37 | chorismate-derived | 1 |
38 | circe | 14 |
39 | concentration-dependant | 2 |
40 | concentration/minimum | 1 |
41 | cone-guided | 1 |
42 | curve/minimum | 1 |
43 | dapk-related | 1 |
44 | dehydration-responsive | 9 |
45 | derivative-are | 1 |
46 | desk-top | 1 |
47 | dir-deformed | 1 |
48 | dosing/minimum | 1 |
49 | double-labeled | 6 |
50 | double-peak | 4 |
51 | eco-environmental | 2 |
52 | effects-an | 1 |
53 | fenofibrate-associated | 2 |
54 | finite | 547 |
55 | four-alternative | 2 |
56 | four-ring | 1 |
57 | galβ1-3galnac | 2 |
58 | half-maximal | 67 |
59 | half‑maximal | 1 |
60 | heat-fraction-limited | 1 |
61 | heterosegmental | 1 |
62 | hewlett-packard | 6 |
63 | higher-energy | 4 |
64 | hyper-corrective | 1 |
65 | igg-associated | 3 |
66 | igg-dependent | 1 |
67 | improved-free | 2 |
68 | introdução | 1 |
69 | isodense | 1 |
70 | itim-bearing | 1 |
71 | j-p2/3 | 6 |
72 | low-alcohol | 4 |
73 | low-pitched | 2 |
74 | lower-than | 1 |
75 | lpp1was | 1 |
76 | maintenance-focused | 1 |
77 | mc-lr/cyn | 6 |
78 | melanin-like | 4 |
79 | menc-specific | 2 |
80 | metal-enhanced | 1 |
81 | microfinite | 1 |
82 | mid-range | 26 |
83 | mid-winter | 1 |
84 | midrange | 20 |
85 | miminum | 1 |
86 | minimum | 5,210 |
87 | minimun | 1 |
88 | mitochondrial-like | 2 |
89 | mr-visualized | 3 |
90 | multifibre | 4 |
91 | myriad | 158 |
92 | naloxone-insensitive | 1 |
93 | naloxone-mediated | 1 |
94 | night-and | 1 |
95 | non-aroclor | 1 |
96 | non-mydriatric | 1 |
97 | non-soluble | 1 |
98 | nonefficacy | 4 |
99 | nres | 5 |
100 | nrs-based | 1 |
101 | oligodynamic | 1 |
102 | onetime | 2 |
103 | orf513 | 4 |
104 | p+ | 14 |
105 | p-leg | 1 |
106 | parallel-elastic | 1 |
107 | pd-specific | 14 |
108 | pedi-cap® | 1 |
109 | polarizable | 18 |
110 | population-derived | 3 |
111 | ppar-response | 1 |
112 | pre-emptive/post-surgery | 1 |
113 | preidentified | 3 |
114 | prospectively-defined | 1 |
115 | protein-engineered | 1 |
116 | proximal-distal | 4 |
117 | pré-incubação | 1 |
118 | q-deformed | 2 |
119 | rac-arpin-arp2/3 | 1 |
120 | rac-wave-arp2/3 | 1 |
121 | randomized-by-site | 1 |
122 | rectoanal | 7 |
123 | roc-derived | 3 |
124 | sars-cov-induced | 1 |
125 | semi-indispensable | 1 |
126 | six-member | 3 |
127 | smaller-than-expected | 4 |
128 | sp1-like | 1 |
129 | spread-out | 1 |
130 | sub-minimum | 1 |
131 | subgroup-the | 1 |
132 | subminimal | 2 |
133 | subminimum | 1 |
134 | surfeit | 7 |
135 | terrace | 7 |
136 | torso-vest | 1 |
137 | tri-modality | 1 |
138 | trial-registration | 2 |
139 | tumour-necrosis-factor-related | 1 |
140 | two-alternative | 11 |
141 | university-wide | 5 |
142 | vademecum | 4 |
143 | venusil | 2 |
144 | vl-absorbing | 1 |
145 | w-box | 3 |
146 | wash-off | 2 |
147 | window-mounted | 1 |
148 | ~0.113 | 1 |
149 | α-amylase/α-glucosidase | 2 |
1 | p+ | 14 |
2 | j-p2/3 | 6 |
3 | rac-wave-arp2/3 | 1 |
4 | rac-arpin-arp2/3 | 1 |
5 | ~0.113 | 1 |
6 | orf513 | 4 |
7 | 142/193 | 1 |
8 | 5.345 | 1 |
9 | 120-kda | 4 |
10 | bregma | 2 |
11 | galβ1-3galnac | 2 |
12 | menc-specific | 2 |
13 | pd-specific | 14 |
14 | oligodynamic | 1 |
15 | non-mydriatric | 1 |
16 | parallel-elastic | 1 |
17 | myriad | 158 |
18 | metal-enhanced | 1 |
19 | sars-cov-induced | 1 |
20 | cone-guided | 1 |
21 | low-pitched | 2 |
22 | preidentified | 3 |
23 | double-labeled | 6 |
24 | q-deformed | 2 |
25 | dir-deformed | 1 |
26 | 'presumed | 1 |
27 | prospectively-defined | 1 |
28 | protein-engineered | 1 |
29 | nrs-based | 1 |
30 | maintenance-focused | 1 |
31 | fenofibrate-associated | 2 |
32 | igg-associated | 3 |
33 | naloxone-mediated | 1 |
34 | dapk-related | 1 |
35 | tumour-necrosis-factor-related | 1 |
36 | smaller-than-expected | 4 |
37 | barrier-protected | 1 |
38 | heat-fraction-limited | 1 |
39 | window-mounted | 1 |
40 | cd40-promoted | 1 |
41 | bodyweight-adjusted | 1 |
42 | roc-derived | 3 |
43 | chorismate-derived | 1 |
44 | population-derived | 3 |
45 | mr-visualized | 3 |
46 | anti-secretory/acid | 1 |
47 | night-and | 1 |
48 | hewlett-packard | 6 |
49 | burkard | 1 |
50 | terrace | 7 |
51 | circe | 14 |
52 | university-wide | 5 |
53 | improved-free | 2 |
54 | mid-range | 26 |
55 | midrange | 20 |
56 | ache/buche | 2 |
57 | subgroup-the | 1 |
58 | sp1-like | 1 |
59 | mitochondrial-like | 2 |
60 | melanin-like | 4 |
61 | semi-indispensable | 1 |
62 | polarizable | 18 |
63 | non-soluble | 1 |
64 | onetime | 2 |
65 | 4-hydroxypiperidine | 2 |
66 | derivative-are | 1 |
67 | multifibre | 4 |
68 | α-amylase/α-glucosidase | 2 |
69 | isodense | 1 |
70 | ppar-response | 1 |
71 | finite | 547 |
72 | microfinite | 1 |
73 | randomized-by-site | 1 |
74 | dehydration-responsive | 9 |
75 | two-alternative | 11 |
76 | four-alternative | 2 |
77 | hyper-corrective | 1 |
78 | naloxone-insensitive | 1 |
79 | wash-off | 2 |
80 | p-leg | 1 |
81 | vl-absorbing | 1 |
82 | four-ring | 1 |
83 | itim-bearing | 1 |
84 | aepg | 1 |
85 | 23-h | 7 |
86 | algal-growth | 1 |
87 | double-peak | 4 |
88 | subminimal | 2 |
89 | half-maximal | 67 |
90 | half‑maximal | 1 |
91 | rectoanal | 7 |
92 | heterosegmental | 1 |
93 | eco-environmental | 2 |
94 | proximal-distal | 4 |
95 | 10-year-survival | 2 |
96 | venusil | 2 |
97 | 5500-ml | 1 |
98 | low-alcohol | 4 |
99 | 2,2-diphenyl-1-picryl-hydrozyl | 2 |
100 | 200-cm | 4 |
101 | 50-cm | 1 |
102 | 15-mm | 11 |
103 | 'uniform | 2 |
104 | vademecum | 4 |
105 | minimum | 5,210 |
106 | sub-minimum | 1 |
107 | curve/minimum | 1 |
108 | dosing/minimum | 1 |
109 | concentration/minimum | 1 |
110 | subminimum | 1 |
111 | 1/8xminimum | 1 |
112 | miminum | 1 |
113 | effects-an | 1 |
114 | lower-than | 1 |
115 | 6-carbon | 3 |
116 | trial-registration | 2 |
117 | minimun | 1 |
118 | mc-lr/cyn | 6 |
119 | 3-to | 3 |
120 | 4-to | 3 |
121 | 6-to | 2 |
122 | 6to | 1 |
123 | pré-incubação | 1 |
124 | introdução | 1 |
125 | desk-top | 1 |
126 | six-member | 3 |
127 | mid-winter | 1 |
128 | berlin-frankfurt-munster | 3 |
129 | 20-hr | 2 |
130 | non-aroclor | 1 |
131 | lpp1was | 1 |
132 | nres | 5 |
133 | 4-class | 7 |
134 | 6-contact | 1 |
135 | surfeit | 7 |
136 | concentration-dependant | 2 |
137 | carbohydrate-predominant | 1 |
138 | analyte-dependent | 1 |
139 | igg-dependent | 1 |
140 | torso-vest | 1 |
141 | 'lowest | 4 |
142 | spread-out | 1 |
143 | 20-msv | 1 |
144 | w-box | 3 |
145 | nonefficacy | 4 |
146 | higher-energy | 4 |
147 | pre-emptive/post-surgery | 1 |
148 | tri-modality | 1 |
149 | pedi-cap® | 1 |